Phase I trial of tedalinab tolerability and pharmacokinetics after single or multiple doses in healthy adults.
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2009
At a glance
- Drugs Tedalinab (Primary)
- Indications Neuropathic pain; Pain
- Focus Adverse reactions
- Sponsors Glenmark Pharmaceuticals Ltd
- 13 Apr 2009 Status changed from recruiting to completed, based on information from a Glenmark media release.
- 18 Jul 2008 New trial record.